(XBIT)
NMS – Real Time Price. Currency in USD
2.27
-0.04 (-1.73%)
At close: Mar 27, 2026, 4:00 PM EDT
2.37
+0.10 (4.41%)
After-hours: Mar 27, 2026, 6:46 PM EDT
Get all premium features to the best stock analysis tool
NMS – Real Time Price. Currency in USD
2.27
-0.04 (-1.73%)
At close: Mar 27, 2026, 4:00 PM EDT
2.37
+0.10 (4.41%)
After-hours: Mar 27, 2026, 6:46 PM EDT
XBiotech Inc., a biopharmaceutical company, discovers, and develops, True Human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.
| Name | Position |
|---|---|
| Dr. Qian Wu | Senior Vice President of Clinical Operations & Analytical Quality |
| Dr. Sushma Shivaswamy Ph.D. | Interim CEO & Chief Scientific Officer |
| Mr. John Simard | Founder & Chairman |
| Ms. Angela Hu | Director of Finance |
| Date | Type | Document |
|---|---|---|
| 2026-03-13 | 10-K | xbit20251231_10k.htm |
| 2026-03-11 | S-8 | fs8_031126.htm |
| 2025-12-09 | 8-K | f8k_120825.htm |
| 2025-11-12 | 10-Q | xbit20250930_10q.htm |
| 2025-10-15 | 8-K/A | f8ka_101525.htm |
| 2025-10-03 | 8-K | f8k_100325.htm |
| 2025-09-02 | 8-K | f8k_090225.htm |
| 2025-08-13 | 10-Q | xbit20250630_10q.htm |
| 2025-07-07 | DEF 14A | d925812ddef14a.htm |
| 2025-06-24 | 8-K | f8k_062425.htm |